Pilot Study: Parkinson's Conventional Physiotherapy vs Home-based Telerehabilitation
PD-REHAB-NET
Management of Initial Parkinson's Disease: a Prospective, Mono-centric, no Profit Pilot Clinical Trial Comparing Conventional Face-to-face Physiotherapy and Home-based Telerehabilitation
1 other identifier
interventional
40
1 country
1
Brief Summary
The Parkinson TELEREHABilitation-NET pilot study (Parkinson TELEREHAB-NET) is designed to observe and monitor PD patients in their initial phase (which includes the period from the onset of motor symptoms until the onset of motor fluctuations) and to assess the feasibility of an integrated multidimensional approach in treating and managing PD patients in a local clinical setting (ASL CN1). Chiefly, through this pilot study, feasibility and acceptability of the general experimental plan, as well as the potential for positive effects of physiotherapy in early PD patients will be assessed. So, this pilot study primarily aims at:
- 1.validating the feasibility of the study protocol, assessing participants' inclusion and exclusion criteria, testing instruments/procedures used for home rehabilitation (both for the Telerehabilitation Exercise group - TrE arm and for the Home Self-Exercise group - HSE arm), testing the suitability of the method for data collection;
- 2.obtaining the required preliminary data for the calculation of a sample size for the primary outcome, in both arms;
- 3.evaluating appropriateness of the consent form, recruitment potentials, time needed to receive written consent, and the required number of researchers/medical specialists/physiotherapists needed to cover the whole study path;
- 4.assessing patients' acceptability of the intervention, through the evaluation of the adherence to rehabilitation process (in both arms), the completeness of proposed measurements, and compliance at follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 25, 2023
CompletedStudy Start
First participant enrolled
October 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedAugust 6, 2024
August 1, 2024
12 months
September 11, 2023
August 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Study recruitment potentials
total number of enrolled subjects / total number of eligible subjects
baseline
Single arm recruitment potentials
arm-specific number of enrolled subjects / arm-specific number of eligible subjects
baseline
Adherence to study path
drop-out rate at each single step, total and by arm
at end of outpatient intensive exercise program (4 weeks from baseline), after training at home (8 weeks from baseline), and for home-based training (follow-ups at 6 months and at 12 months from baseline)
Compliance to interventions
number of fulfilled visits / number of scheduled visits
at end of outpatient intensive exercise program (4 weeks from baseline), after training at home (8 weeks from baseline), and for home-based training (follow-ups at 6 months and at 12 months from baseline)
Secondary Outcomes (13)
Cognitive functions
from baseline to follow-ups (at 6 months and at 12 months from baseline)
Freezing of gait
from baseline to follow-ups (at 6 months and at 12 months from baseline)
Movement disorders
from baseline to follow-ups (at 6 months and at 12 months from baseline)
Postural control
from baseline to follow-ups (at 6 months and at 12 months from baseline)
Sensory orientation
from baseline to follow-ups (at 6 months and at 12 months from baseline)
- +8 more secondary outcomes
Study Arms (2)
Telerehabilitation Exercise group (TrE arm)
EXPERIMENTALHome Self-Exercise group (HSE arm)
ACTIVE COMPARATORInterventions
After the outpatient intensive physical therapy program (common to both study arms), patients in the TrE group will continue with prescribed self-training at home through telerehabilitation, at least 3 times a week for 4 weeks. Each physical exercise session will consist of at least 5 minutes of aerobic warming-up, 35 minutes of specific high-intensity exercises for PD, and 5 minutes of aerobic cool-down. The TrE arm will be supported by a telerehabilitation device which will be installed and tested at the patients' home immediately after the outpatient intensive program. The device will track any access and exercise duration, so that the physiotherapists will be able to remotely monitor both the actual duration of each session and their weekly frequency. One session per week will be directly and online supervised by a physiotherapist, while the other two will be recorded only.
After the outpatient intensive physical therapy program (common to both study arms), patients in the HSE group will continue with prescribed self-training at home, at least 3 times a week for 4 weeks. Each physical exercise session will consist of at least 5 minutes of aerobic warming-up, 35 minutes of specific high-intensity exercises for PD, and 5 minutes of aerobic cool-down. The HSE arm will be given a booklet containing detailed explanations and pictures of the assigned exercises, in order to guide them in the correct execution of the requested movements. Subjects in this group will be asked to fill in a training diary to keep track of the training sessions and their duration. Once a week a physiotherapist will contact patients to discuss possible problems encountered in performing the exercises and to help in solving them.
Eligibility Criteria
You may qualify if:
- General:
- adults, aged 18 or older;
- medical diagnosis of idiopathic PD according the most recent Movement Disorder Society diagnostic criteria;
- disease stage ≤ 2 on the Hoehn\&Yahr scale;
- Montreal Cognitive Assessment score \>25;
- ability to read, understand and provide a written informed consent, in accordance with good clinical practice and local regulations;
- motivation and possibility to show up for planned controls and to comply with the requested study procedures.
- Specific for TrE arm:
- wireless internet access at home;
- adequate room to place telerehabilitation device (about 2 meters in front of device monitor).
You may not qualify if:
- \<18 years of age;
- Any atypical, iatrogenic, or secondary Parkinsonism;
- Disease stage \> 2 on the Hoehn\&Yahr scale;
- Any severe orthopaedic, vascular, respiratory, or cardiac problems or any other medical condition that, in the principal investigator's opinion, could limit participation in moderate exercise or the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Sanitaria Locale CN1
Cuneo, 12030, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elona Brahimi, MD
Neurology Unit, Movement Disorders Clinic , Local Health Authority, ASL Cuneo 1, Italy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 25, 2023
Study Start
October 9, 2023
Primary Completion
October 1, 2024
Study Completion
October 1, 2025
Last Updated
August 6, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share